Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Pharmacogenomics and Opioid Analgesics: Clinical Implications.

Yiannakopoulou E.

Int J Genomics. 2015;2015:368979. doi: 10.1155/2015/368979. Epub 2015 May 14. Review.

2.

Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.

Biesiada J, Chidambaran V, Wagner M, Zhang X, Martin LJ, Meller J, Sadhasivam S.

Pharmacogenomics. 2014 Nov;15(14):1749-1762.

3.

Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

Poonai N, Bhullar G, Lin K, Papini A, Mainprize D, Howard J, Teefy J, Bale M, Langford C, Lim R, Stitt L, Rieder MJ, Ali S.

CMAJ. 2014 Dec 9;186(18):1358-63. doi: 10.1503/cmaj.140907. Epub 2014 Oct 27.

4.

Pharmacogenomics and adverse drug reactions in children.

Rieder MJ, Carleton B.

Front Genet. 2014 Apr 16;5:78. doi: 10.3389/fgene.2014.00078. eCollection 2014. Review.

5.

The emerging era of pharmacogenomics: current successes, future potential, and challenges.

Lee JW, Aminkeng F, Bhavsar AP, Shaw K, Carleton BC, Hayden MR, Ross CJ.

Clin Genet. 2014 Jul;86(1):21-8. doi: 10.1111/cge.12392. Epub 2014 May 9. Review.

6.

Oxycodone overdose in the pediatric population: case files of the University of Massachusetts Medical Toxicology Fellowship.

Boyle KL, Rosenbaum CD.

J Med Toxicol. 2014 Sep;10(3):280-5. doi: 10.1007/s13181-014-0394-3. No abstract available.

7.

Doing without codeine: why and what are the alternatives?

Benini F, Barbi E.

Ital J Pediatr. 2014 Feb 11;40(1):16. doi: 10.1186/1824-7288-40-16.

8.

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, Haidar CE, Shen DD, Callaghan JT, Sadhasivam S, Prows CA, Kharasch ED, Skaar TC; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2014 Apr;95(4):376-82. doi: 10.1038/clpt.2013.254. Epub 2014 Jan 23. Review.

9.

Pharmacogenetic testing: Current Evidence of Clinical Utility.

Moaddeb J, Haga SB.

Ther Adv Drug Saf. 2013 Aug 1;4(4):155-169.

10.

Pain management in children: Part 2 - A transition from codeine to morphine for moderate to severe pain in children.

Wong C, Lau E, Palozzi L, Campbell F.

Can Pharm J (Ott). 2012 Nov;145(6):276-279.e1. doi: 10.3821/145.6.cpj276. No abstract available.

11.

Pharmacogenomic considerations in opioid analgesia.

Vuilleumier PH, Stamer UM, Landau R.

Pharmgenomics Pers Med. 2012;5:73-87. doi: 10.2147/PGPM.S23422. Epub 2012 Aug 23. Erratum in: Pharmgenomics Pers Med. 2013;6:1.

12.

Parent satisfaction with acute pediatric pain treatment at home.

Gill M, Drendel AL, Weisman SJ.

Clin J Pain. 2013 Jan;29(1):64-9. doi: 10.1097/AJP.0b013e3182454a9e.

13.

Systems pharmacology: network analysis to identify multiscale mechanisms of drug action.

Zhao S, Iyengar R.

Annu Rev Pharmacol Toxicol. 2012;52:505-21. doi: 10.1146/annurev-pharmtox-010611-134520. Review.

14.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.

Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, Kharasch ED, Skaar TC; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2012 Feb;91(2):321-6. doi: 10.1038/clpt.2011.287. Epub 2011 Dec 28.

15.

Baby boy blue - why is this newborn lethargic?

Rieder M, Koren G.

Paediatr Child Health. 2010 Nov;15(9):571-2. No abstract available.

16.

Copy number variants in pharmacogenetic genes.

He Y, Hoskins JM, McLeod HL.

Trends Mol Med. 2011 May;17(5):244-51. doi: 10.1016/j.molmed.2011.01.007. Epub 2011 Mar 8. Review.

17.

Has the time come to phase out codeine?

MacDonald N, MacLeod SM.

CMAJ. 2010 Nov 23;182(17):1825. doi: 10.1503/cmaj.101411. Epub 2010 Oct 4. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk